Zanamivir News

Latest Zanamivir News

Sat, 31 Jul 2010 11:59:19 +0200

Zanamivir News updated every 15 minutes. Stay informed on latest Zanamivir Avian Influenza H5N1 News.

Influenza Viruses killed by Ultraviolet Air Purifiers

Sat, 31 Jul 2010 11:59:19 +0200

A main cause of influenza is through inhalation of virus particles that are spread by sick people coughing and sneezing. During a pandemic flu one of the few ways to reduce the risk of spread to yourself or others is to trap the virus particles with a specialized air purifier that is equipped with an ultraviolet light. As the virus is drawn into the purifier the ultraviolet light kills it. Find out more about ultraviolet air purifiers ...

Evidence on zanamivir .

The National Institute of Clinical Excellence (NICE) has issued guidance to the NHS concerning the use of zanamivir in the treatment of influenza. It has also posted on its Internet site (www.nice.org.uk) a summary of the evidence used in making its decision ...

Biota Announces Zanamivir Will Enter Phase III Clinical Trials in May 1997

MELBOURNE, Australia, Feb. 24 /PRNewswire/ -- Biota Holdings Limited (Australian Stock Exchange: BTA) today announced that Glaxo Wellcome p1c, the Company's development partner, has informed management that Phase III clinical trials of zanamivir, or GG167, for the treatment of influenza, planned to ...

Transmission within Families Reduced with Zanamivir.

2000 NOV 21 - (NewsRx.com) -- Families like to share a lot of things, but the flu shouldn't be one of them. A new study, published in the November 2, 2000, issue of the New England Journal of Medicine, found that zanamivir can prevent the flu from making the rounds within a family when one member ...

Drug to treat flu also protects against it.

For 3 decades, scientists have been experimenting with medications that stifle the influenza virus. Two drugs, amantadine and rimantadine, can impede the disease and limit symptoms. However, neither works against one of the two major strains of influenza, and both can be eluded by the evolving ...

Faster Relief from Influenza Symptoms for 'High Risk' and Otherwise Healthy Patients with Inhaled Zanamivir.

Clinical Trial Data Show Up to a 2.5-Day Reduction in Time to Alleviation of Symptoms of Influenza MELBOURNE, Australia, Nov. 17 /PRNewswire/ -- Biota Holdings Limited has been advised by its development partner, Glaxo Wellcome (NYSE: GLX), that the results of two Phase III clinical trials of ...

The cost effectiveness of zanamivir and oseltamivir for influenza treatment

ABSTRACT In this month's column, the authors evaluate the cost effectiveness of oseltamivir and zanamivir, compared with standard care, for the treatment of influenza. Using efficacy data from randomized, placebo-controlled clinical trials, a cost-effectiveness model was constructed. In an ...

Inhaled Zanamivir Beats Rimantadine.

TORONTO -- The new, inhaled anti-influenza drug, zanamivir, was more effective than rimantadine for preventing flu transmission in nursing homes in a head-to-head comparison. This finding "supports the use of zanamivir for institutional outbreak control," Dr. Stefan Gravenstein said at the annual ...

Zanamivir provides effective influenza prophylaxis in exposed family members

San Francisco-The inhaled neuraminidase inhibitor zanamivir can prevent influenza acquisition within families, reported Frederick Hayden, MD. The drug, which recently received market clearance for the treatment of influenza, works by inhibiting the neuraminidase of both influenza A and B viruses. ...

Zanamivir for Inhalation (Relenza--Glaxo Welcome).

JUST IN TIME FOR THE 1999 FLU SEASON, THE FDA HAS approved Glaxo Wellcome's zanamivir (Relenza) for the treatment of influenza A and B. Zanamivir is the first of a new class of antiviral drugs, the sialic acid analogs, which were developed though computer-assisted design. These drugs are believed ...

Zanamivir for Inhalation (Relenza-Glaxo Wellcome).

Pharmacology Update Zanamivir for Inhalation (RelenzaGlaxo Wellcome) By William T. Elliott, MD, FACP, and James Chan, PharmD, PhD Just in time for the 1999 flu season, the fda has approved Glaxo Wellcomes zanamivir (Relenza) for the treatment of influenza A and B virus infections. Zanamivir is the ...

COLD-fX : "Impressive" concludes leading American cold/flu experts in new U.S. scientific report

Sat, 31 Jul 2010 11:59:19 +0200

A major U.S. scientific review (monograph) of COLD-fX conducted by leading American cold/flu experts concludes the cold/flu remedy delivered "impressive" benefits to users.
COLD-fX is the result of intensive scientific research on a natural herb, American ginseng root. It is believed to be the first natural medicine in Canada approved to fight colds and flu by boosting the immune system. In the United States, COLD-fX is classified and regulated as a dietary supplement.
Many of the world's top athletes rely on COLD-fX to strengthen their immune systems, prepare for the rigors of training, and protect themselves against everyday stresses. Find out more about COLD-fX >>